Cargando…

Roundabout Guidance Receptor 1 Is an Emerging Prognostic Biomarker for Nasopharyngeal Carcinoma

BACKGROUND: Nasopharyngeal carcinoma (NPC) is a malignant tumor originating from the nasopharynx with high morbidity and mortality in Southeast Asia and south of China. Roundabout guidance receptor 1 (ROBO1) can regulate axonogenesis (axon-like protrusion), which may play an important role in migrat...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Sung-Wei, Yang, Ching-Chieh, Lai, Hong-Yue, Tsai, Hsin-Hwa, Yeh, Cheng-Fa, Kuo, Yu-Hsuan, Kang, Nai-Wen, Chen, Tzu-Ju, Chang, Shih-Lun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310334/
https://www.ncbi.nlm.nih.gov/pubmed/35898392
http://dx.doi.org/10.1177/11795549221113244
_version_ 1784753363468943360
author Lee, Sung-Wei
Yang, Ching-Chieh
Lai, Hong-Yue
Tsai, Hsin-Hwa
Yeh, Cheng-Fa
Kuo, Yu-Hsuan
Kang, Nai-Wen
Chen, Tzu-Ju
Chang, Shih-Lun
author_facet Lee, Sung-Wei
Yang, Ching-Chieh
Lai, Hong-Yue
Tsai, Hsin-Hwa
Yeh, Cheng-Fa
Kuo, Yu-Hsuan
Kang, Nai-Wen
Chen, Tzu-Ju
Chang, Shih-Lun
author_sort Lee, Sung-Wei
collection PubMed
description BACKGROUND: Nasopharyngeal carcinoma (NPC) is a malignant tumor originating from the nasopharynx with high morbidity and mortality in Southeast Asia and south of China. Roundabout guidance receptor 1 (ROBO1) can regulate axonogenesis (axon-like protrusion), which may play an important role in migration. However, the roles of ROBO1 in NPC have not been clarified. METHODS: A comparative analysis employing the NPC transcriptome (GSE12452) and the axonogenesis-related genes (GO: 0050772) was performed. In total, 124 tissue blocks from patients primarily diagnosed as NPC (1993-2002) were examined using immunohistochemical staining. The connections between clinicopathological variables and protein immunoexpression were analyzed by Pearson’s chi-square test. The Kaplan–Meier method with a log-rank test was employed to plot survival curves. Multivariate analysis was performed using the Cox proportional hazards model to identify independent prognostic biomarker. RESULTS: According to transcriptome analysis, we found that ROBO1 is significantly highly expressed in NPC tissues compared with normal tissues. The immunohistochemistry (IHC) staining showed that high expression of ROBO1 was significantly related to primary tumor (T1T2 and T3T4) (P = .024), nodal metastasis status (N0N1 and N2N3) (P = .030), stage (I-II and III-IV) (P = .019), and histological grade (keratinizing, non-keratinizing, and undifferentiated) (P = .065). Importantly, NPC patients with high ROBO1 expression had poorer disease-specific survival (DSS) (P = .0001), distal metastasis-free survival (DMeFS) (P < .0001), and local recurrence-free survival (LRFS) (P = .0001) compared with NPC patients with low ROBO1 expression through the uni-/multivariate and the Kaplan–Meier survival analyses. CONCLUSION: Our report indicates that ROBO1 might be a potential prognostic biomarker for NPC.
format Online
Article
Text
id pubmed-9310334
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-93103342022-07-26 Roundabout Guidance Receptor 1 Is an Emerging Prognostic Biomarker for Nasopharyngeal Carcinoma Lee, Sung-Wei Yang, Ching-Chieh Lai, Hong-Yue Tsai, Hsin-Hwa Yeh, Cheng-Fa Kuo, Yu-Hsuan Kang, Nai-Wen Chen, Tzu-Ju Chang, Shih-Lun Clin Med Insights Oncol Special Topic: Head and Neck Cancers: Current Concepts in the Diagnosis, Management, Reconstruction, and Rehabilitation BACKGROUND: Nasopharyngeal carcinoma (NPC) is a malignant tumor originating from the nasopharynx with high morbidity and mortality in Southeast Asia and south of China. Roundabout guidance receptor 1 (ROBO1) can regulate axonogenesis (axon-like protrusion), which may play an important role in migration. However, the roles of ROBO1 in NPC have not been clarified. METHODS: A comparative analysis employing the NPC transcriptome (GSE12452) and the axonogenesis-related genes (GO: 0050772) was performed. In total, 124 tissue blocks from patients primarily diagnosed as NPC (1993-2002) were examined using immunohistochemical staining. The connections between clinicopathological variables and protein immunoexpression were analyzed by Pearson’s chi-square test. The Kaplan–Meier method with a log-rank test was employed to plot survival curves. Multivariate analysis was performed using the Cox proportional hazards model to identify independent prognostic biomarker. RESULTS: According to transcriptome analysis, we found that ROBO1 is significantly highly expressed in NPC tissues compared with normal tissues. The immunohistochemistry (IHC) staining showed that high expression of ROBO1 was significantly related to primary tumor (T1T2 and T3T4) (P = .024), nodal metastasis status (N0N1 and N2N3) (P = .030), stage (I-II and III-IV) (P = .019), and histological grade (keratinizing, non-keratinizing, and undifferentiated) (P = .065). Importantly, NPC patients with high ROBO1 expression had poorer disease-specific survival (DSS) (P = .0001), distal metastasis-free survival (DMeFS) (P < .0001), and local recurrence-free survival (LRFS) (P = .0001) compared with NPC patients with low ROBO1 expression through the uni-/multivariate and the Kaplan–Meier survival analyses. CONCLUSION: Our report indicates that ROBO1 might be a potential prognostic biomarker for NPC. SAGE Publications 2022-07-22 /pmc/articles/PMC9310334/ /pubmed/35898392 http://dx.doi.org/10.1177/11795549221113244 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page(https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Special Topic: Head and Neck Cancers: Current Concepts in the Diagnosis, Management, Reconstruction, and Rehabilitation
Lee, Sung-Wei
Yang, Ching-Chieh
Lai, Hong-Yue
Tsai, Hsin-Hwa
Yeh, Cheng-Fa
Kuo, Yu-Hsuan
Kang, Nai-Wen
Chen, Tzu-Ju
Chang, Shih-Lun
Roundabout Guidance Receptor 1 Is an Emerging Prognostic Biomarker for Nasopharyngeal Carcinoma
title Roundabout Guidance Receptor 1 Is an Emerging Prognostic Biomarker for Nasopharyngeal Carcinoma
title_full Roundabout Guidance Receptor 1 Is an Emerging Prognostic Biomarker for Nasopharyngeal Carcinoma
title_fullStr Roundabout Guidance Receptor 1 Is an Emerging Prognostic Biomarker for Nasopharyngeal Carcinoma
title_full_unstemmed Roundabout Guidance Receptor 1 Is an Emerging Prognostic Biomarker for Nasopharyngeal Carcinoma
title_short Roundabout Guidance Receptor 1 Is an Emerging Prognostic Biomarker for Nasopharyngeal Carcinoma
title_sort roundabout guidance receptor 1 is an emerging prognostic biomarker for nasopharyngeal carcinoma
topic Special Topic: Head and Neck Cancers: Current Concepts in the Diagnosis, Management, Reconstruction, and Rehabilitation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310334/
https://www.ncbi.nlm.nih.gov/pubmed/35898392
http://dx.doi.org/10.1177/11795549221113244
work_keys_str_mv AT leesungwei roundaboutguidancereceptor1isanemergingprognosticbiomarkerfornasopharyngealcarcinoma
AT yangchingchieh roundaboutguidancereceptor1isanemergingprognosticbiomarkerfornasopharyngealcarcinoma
AT laihongyue roundaboutguidancereceptor1isanemergingprognosticbiomarkerfornasopharyngealcarcinoma
AT tsaihsinhwa roundaboutguidancereceptor1isanemergingprognosticbiomarkerfornasopharyngealcarcinoma
AT yehchengfa roundaboutguidancereceptor1isanemergingprognosticbiomarkerfornasopharyngealcarcinoma
AT kuoyuhsuan roundaboutguidancereceptor1isanemergingprognosticbiomarkerfornasopharyngealcarcinoma
AT kangnaiwen roundaboutguidancereceptor1isanemergingprognosticbiomarkerfornasopharyngealcarcinoma
AT chentzuju roundaboutguidancereceptor1isanemergingprognosticbiomarkerfornasopharyngealcarcinoma
AT changshihlun roundaboutguidancereceptor1isanemergingprognosticbiomarkerfornasopharyngealcarcinoma